Admetsys is at the forefront of critical care technology, focusing on high-precision automation tailored to individual patient needs. Their flagship product, the PrecisionOne™ Clinical Automation Controller, utilizes advanced biosensors to create a real-time AI model of each patient's metabolism. This system autonomously manages glucose levels by continuously infusing optimized insulin and dextrose, eliminating the need for clinician intervention. Additionally, the Intravenous Laboratory™ offers real-time continuous blood diagnostics through a cartridge-based design that can analyze multiple blood parameters, such as glucose and lactate, without causing blood loss to the patient. This capability is crucial for early sepsis detection and effective metabolic control, which are vital for improving patient outcomes in critical care settings.

The technologies developed by Admetsys significantly enhance workflow efficiency and patient safety in critical care environments. Traditional methods of blood analysis and glucose control are labor-intensive and prone to human error, often requiring multiple blood draws and clinician calculations. In contrast, Admetsys' automated systems reduce the clinical burden, allowing for more precise and timely interventions. Clinical trials have demonstrated the effectiveness of PrecisionOne™, achieving a 97% control rate for glucose levels and 100% prevention of hypoglycemia, while also minimizing the time clinicians spend on these tasks. This innovative approach not only improves patient care but also addresses the growing shortage of skilled clinical personnel, ultimately leading to better resource management in hospitals.

United States

Admetsys is a biomedical technology company specializing in critical care automation. The company's flagship PrecisionOne system is the first fully automated glycemic control system and continuous blood diagnostics platform for hospital care. The company was founded to commercialize the next generation of medical automation technology: continuous real-time biosensing, robotics, artificial intelligence and learning algorithms, intelligent therapeutic delivery, and advanced data telemetry.

Admetsys

Company Details